After-Hours Stock Movers 08/02: (TBIO) (PCSA) (SEDG) Higher; (RNA) (ADUS) (SANM) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Avidity Biosciences Inc. (RNA) Prices 8M Share Offering at $18/sh
August 4, 2021 5:30 AM EDTAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of... More
Take-Two Interactive (TTWO) PT Lowered to $230 at Stifel
August 3, 2021 12:29 PM EDTStifel analyst Drew E. Crum lowered the price target on Take-Two Interactive (NASDAQ: TTWO) to $230.00 (from $237.00) while maintaining a Buy rating.
The analyst commented, "Take-Two reported its FY1Q which featured y/y declines (as anticipated), reflecting tough comps and an uptick in... More
Varonis Systems (VRNS) PT Lowered to $65 at Baird
August 3, 2021 9:12 AM EDTBaird analyst Jonathan Ruykhaver lowered the price target on Varonis Systems (NASDAQ: VRNS) to $65.00 (from $67.00) while maintaining a Neutral rating.
The analyst commented, "Varonis posted solid 2Q results, beating consensus expectations for revenue, ARR, and non-GAAP EPS in the quarter. Overall commentary... More
Harmonic Inc. (HLIT) PT Raised to $13 at Needham & Company
August 3, 2021 6:49 AM EDTNeedham & Company analyst Ryan Koontz raised the price target on Harmonic Inc. (NASDAQ: HLIT) to $13.00 (from $9.50) while maintaining a Buy rating.
The analyst commented, "HLIT reported a solid 2Q21 top and bottom line beat and raised 2H21 guidance, lifting the stock (+8% AH).... More
